The Trump Administration recently released “An Update on the President’s Commission on Combating Drug Addiction and the Opioid Epidemic: One Year Later”, a report that details the progress the Administration has made in collaboration with legislatures, communities, and law enforcement to address the opioid epidemic in America.
In the last two years, over $6 billion in funding has been secured to address the opioid epidemic, opioid prescriptions have dropped by 34% and $500 million has been invested into developing non-addictive pain management therapies. The Trump Administration has also made progress stopping online drug trafficking by disrupting online sales of illicit opioids through the DoJ’s Joint Criminal Opioid Darknet. Enforcement.
Expanding access to medications that treat addiction and reverse overdoses has also been a key priority. Since 2017, the number of people being prescribed buprenorphine increased by 23%, while naltrexone prescriptions increased by 42%. The number of prescriptions for naloxone, a lifesaving treatment that reverses overdoses, increased 484% since the president took office. In addition to the impressive increase in naloxone prescriptions, private-public partnerships with universities, libraries, high schools, and community centers should help make naloxone more accessible than ever before.
With a focus on private-public partnerships, enhanced education for medical professionals, and strengthening law enforcement efforts, the Trump Administration is prioritizing a comprehensive response to the opioid epidemic.